small molecule

KAITLIB FE

ETHINYL ESTRADIOL; NORETHINDRONE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameKAITLIB FE
Active ingredientETHINYL ESTRADIOL; NORETHINDRONE
Strength0.025MG;0.8MG
Dosage formTABLET, CHEWABLE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2015
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.